Breaks Categories: Stock Spotlights

ThursdayJul 18, 2019 2:48 pm

CannabisNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Adds Top-Tier Executive to Ranks

TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently named Alan R. Applonie as general manager of its Modesto facility (http://cnw.fm/Rp1oX). A recent article discussing the company reads, “The appointment was made after screening of top-tier talent from the industry for a period of six months. Applonie most recently oversaw a major consumer-goods facility that generated approximately $300 million in annual gross revenues. He will be overseeing all of the manufacturing and related activities at the 196,000-square-foot hub, as well as other units being acquired in Stanislaus County. . . . With this one single move, TransCanna has instilled years of experience, knowledge…

Continue Reading

ThursdayJul 18, 2019 2:39 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Consistently Outperforms Industry Standards

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently reported that clinical lab tests conducted with live animals demonstrated that its new, enhanced version of DehydraTECH(TM)  can deliver eight times more CBD into the blood and 19 times more CBD into the brain tissue than standard industry formulations (http://cnw.fm/0sJRF). An article discussing the company reads, “LXRP intends to perform more studies on the enhanced DehydraTECH and focus on optimizing implementation regarding product applications for its licensees. . . . In earlier test results, LXRP announced that original or standard DehydraTECH combined with generic nanotech techniques delivers 1,137% more cannabidiol (CBD)…

Continue Reading

WednesdayJul 17, 2019 2:59 pm

CannabisNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Focuses on Expanding Suite of CBD, Hemp-Derived Products

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF), a Vancouver-based cannabis company, recently secured a new spot for its CBD-based SKUs at almost 300 stores nationwide through the completion of a distribution deal with Dillard’s. A recent article discussing the company reads, “Wildflower announced June 17 (http://cnw.fm/Uq2j1) that the company has received and fulfilled an opening purchase order from Dillard’s department stores that will give Wildflower’s premium hemp SKUs a presence in 292 Dillard’s stores nationwide. The deal is particularly attractive because it gives Wildflower an access channel in the large markets of Florida and Texas. . . . ‘Launching into Dillard’s…

Continue Reading

FridayJul 12, 2019 2:51 pm

CannabisNewsBreaks – Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Acquires 49% Interest in Budding Cannabis Industry Disruptor

Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P), a leading Canadian investment company with specialty investments in assets across multiple divisions of the cannabis sector, recently reported the completion of its purchase of a 49% interest in Cannova Medical Ltd. The company also holds the option to acquire the remaining 51% interest in Cannova. A recent article discussing the company reads, “Cannova Medical is a provider of innovative solutions for cannabis consumption. Pursuing its interest in investment across all vertically integrated aspects of the cannabis sector, with a focus on strategic revenue generation, Nabis selected Cannova because of its innovative…

Continue Reading

ThursdayJul 11, 2019 3:26 pm

CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Secures Coveted Standard Processing License

Geyser Brands’ (TSX.V: GYSR) wholly owned subsidiary, Apothecary Botanicals, recently achieved a major milestone when it received its standard processing license, enabling Geyser to advance its brands (http://cnw.fm/8FyOi). An article discussing the company reads, “The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its sales license. The company’s nano-emulsion technology carries oil and hemp terpene-infused benefits quickly and efficiently into the bloodstream for rapid relief of pain while boosting the body’s general abilities with all-natural ingredients. . . . In keeping with its mission to develop…

Continue Reading

ThursdayJul 11, 2019 2:40 pm

CannabisNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Focuses on Expanding Suite of CBD, Hemp-Derived Products

Vancouver-based cannabis company Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) has been diligently working on a strategic initiative to expand its product offerings. A recent article discussing the company reads, “In March 2019, the company announced that it was expanding its offerings through the introduction of Pure and Pure Plus tinctures. Both feature hemp-derived CBD, hemp-seed oil and milk thistle. The tinctures provide relief from inflammation and support for healthy liver and heart function. . . . Wildflower announced that it will continue working on new releases as a part of the company’s ongoing product development efforts. The company has also…

Continue Reading

WednesdayJul 10, 2019 2:15 pm

CannabisNewsBreaks – Why Willow Biosciences Inc. (CSE: WLLW) Is ‘One to Watch’

Alberta, Canada-based Willow Biosciences (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. A recent article discussing Willow Biosciences reads, “The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by chief scientific…

Continue Reading

MondayJul 08, 2019 3:19 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Building Reputation as Leading Organic Cannabis Provider

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, is on a mission to establish itself as an international leader in delivering premium organic cannabis solutions. A recent article discussing the company reads, “The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is making a name for itself as it pursues an upward-scaling strategy of building enclosed facilities for cannabis growth, anticipating that its purpose-built enterprise will progress from about 2,000 kilograms (4,400 pounds) of cannabis at its Ontario site this summer to 100 times that amount across all its sites when it…

Continue Reading

FridayJul 05, 2019 3:30 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Expands Footprint in Western Canada via AGLC Supply Agreement

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently entered a supply agreement with Alberta Gaming, Liquor and Cannabis (“AGLC”) (http://cnw.fm/8Yap2). An article discussing the company’s deal reads, “The agreement with AGLC was negotiated in association with Velvet Management Inc. Velvet Management provides a fully integrated, national sales and distribution platform for TGOD’s premium organic cannabis to provincial liquor and cannabis boards. . . . ‘Alberta is an important market for us as we continue to expand our distribution channels across Canada,’ TGOD CEO Brian Athaide said in a news release. ‘With our…

Continue Reading

FridayJul 05, 2019 1:45 pm

CannabisNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Leverages Proprietary NanoFusion Delivery System throughout Cannabis Industry

Vancouver, British Columbia-based consumer health care company Geyser Brands (TSX.V: GYSR) is engaged in creating first-class, cannabis-focused health care products and brands. A recent article discussing the company reads, “Geyser’s NanoFusion advanced delivery system rapidly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency. NanoFusion provides premier bioavailability and solves problems with insolubility. It also provides a longer shelf life, stability of molecules and enhanced permeation that allows for deeper skin penetration. Moreover, NanoFusion​ improves the transport of active ingredients for site-specific targeting and delivers active ingredients across cell membranes for release within the cell. Its proprietary…

Continue Reading